Kore Fiber for Degenerative Lumbar Spine Disease

This trial tests a new treatment called Kore Fiber for individuals with degenerative lumbar spine disease undergoing spine fusion surgery. The researchers aim to determine if Kore Fiber is more effective or safer than the usual method, an autograft, in aiding proper spine fusion and reducing pain. Participants will receive Kore Fiber on one side of their spine and the autograft on the other. Suitable candidates have experienced spine problems unresponsive to other treatments for at least six months and are scheduled for fusion surgery. As an unphased trial, this study provides a unique opportunity to contribute to pioneering research that could enhance future spine fusion outcomes.

The trial information does not specify whether you need to stop taking your current medications. However, if you are on chemotherapy, radiation, immunosuppressive agents, or chronic steroids, you may not be eligible to participate.

Research on Kore Fiber for treating the lower back remains limited. Specific safety data from previous studies on Kore Fiber is unavailable, making it difficult to determine tolerance levels or potential side effects.

The trial is in the "Not Applicable" phase, which typically involves exploring new or unique treatment comparisons. At this stage, more information is needed about the treatment's safety and effectiveness.

In this trial, researchers compare Kore Fiber to an autograft, a bone graft using the patient's own bone. The trial will closely monitor for any side effects or issues. The goal is to determine if Kore Fiber is as safe and effective as traditional treatments. Although approval for another condition might suggest safety, Kore Fiber has not yet received such approval.

Most treatments for degenerative lumbar spine disease, like autologous bone grafts, involve using the patient's bone for fusion, which can be invasive and require longer recovery times. Kore Fiber offers a unique approach by using a standalone synthetic fiber for spinal fusion. This treatment may reduce the need for additional harvesting of bone from the patient, potentially leading to less pain and faster recovery. Researchers are excited about Kore Fiber because it could simplify the surgical process and improve patient outcomes compared to traditional methods.

Research is exploring Kore Fiber as a potential treatment for degenerative lumbar spine disease. In this trial, participants will receive either Kore Fiber or an autologous bone graft. Kore Fiber aims to assist with spinal fusion, the process of permanently joining two or more bones in the spine. This procedure is crucial for addressing back pain and spinal instability. While data on Kore Fiber's effectiveness in humans remains limited, it resembles autografts, which use a patient's own bone for fusion and have proven effective. The goal is for Kore Fiber to achieve similar or better results without requiring bone from the patient. Early studies on similar materials have shown promise, but further research is necessary to confirm its benefits.⁶⁷⁸⁹¹⁰